# High Dose Ribavirin in the Treatment of Chronic Hepatitis C

> **NCT00944684** · PHASE2 · COMPLETED · sponsor: **University of Bern** · enrollment: 32 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** High ribavirin dose
- **DRUG:** Standard ribavirin dose

## Key facts

- **NCT ID:** NCT00944684
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-11-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944684, "High Dose Ribavirin in the Treatment of Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00944684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*